Black Rock Inc. Bio N Tech Se Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Black Rock Inc. holds 1,895,427 shares of BNTX stock, worth $206 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,895,427
Previous 1,906,841
0.6%
Holding current value
$206 Million
Previous $176 Million
13.41%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BNTX
# of Institutions
336Shares Held
39.9MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$889 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$464 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$441 Million0.31% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$197 Million0.84% of portfolio
-
Capital International Investors Los Angeles, CA1.43MShares$156 Million0.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...